JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Scope & Guideline

Advancing knowledge in thrombosis and thrombolysis.

Introduction

Welcome to the JOURNAL OF THROMBOSIS AND THROMBOLYSIS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JOURNAL OF THROMBOSIS AND THROMBOLYSIS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0929-5305
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1994 to 2024
AbbreviationJ THROMB THROMBOLYS / J. Thromb. Thrombolysis
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The Journal of Thrombosis and Thrombolysis aims to advance the understanding of thrombotic and thrombolytic processes, focusing on the mechanisms, diagnosis, treatment, and prevention of thromboembolic diseases. It encompasses a wide range of topics related to coagulation, anticoagulation therapies, and the impact of various conditions on thrombotic events.
  1. Thromboembolic Disease Research:
    The journal emphasizes research on various forms of thromboembolic diseases, including venous thromboembolism (VTE), pulmonary embolism, and arterial thrombosis, investigating their epidemiology, risk factors, and clinical outcomes.
  2. Anticoagulation Therapy:
    It publishes studies on the efficacy and safety of anticoagulation therapies, including direct oral anticoagulants (DOACs), vitamin K antagonists, and novel anticoagulants, focusing on their use in different patient populations.
  3. Mechanisms of Coagulation and Thrombosis:
    Research exploring the underlying biological mechanisms of coagulation, the role of platelets, and the genetic factors influencing thrombotic events is a core focus, contributing to the understanding of thrombosis at a molecular level.
  4. Clinical Guidelines and Practice:
    The journal provides a platform for the dissemination of clinical guidelines and best practices in the management of thromboembolic diseases, integrating evidence-based medicine into clinical practice.
  5. Innovative Diagnostic Approaches:
    It highlights advancements in diagnostic methodologies for thromboembolic diseases, including imaging techniques and biomarkers, facilitating early detection and management.
Recent years have seen the emergence of several key themes within the Journal of Thrombosis and Thrombolysis, reflecting the evolving landscape in thrombosis research and clinical practice.
  1. COVID-19 Related Thrombosis:
    A significant increase in studies addressing thrombotic complications associated with COVID-19 has emerged, highlighting the pandemic's impact on thromboembolic disease research and management.
  2. Machine Learning and Predictive Analytics:
    There is a growing trend towards utilizing machine learning and predictive analytics in identifying thrombosis risk factors and outcomes, representing a shift towards data-driven approaches in clinical research.
  3. Personalized Anticoagulation Strategies:
    Emerging research focuses on individualized anticoagulation therapy, considering genetic, demographic, and clinical variables to optimize treatment outcomes for patients.
  4. Cancer-Associated Thrombosis:
    An increasing number of studies are dedicated to understanding the mechanisms and management of thrombosis in cancer patients, reflecting the critical interplay between malignancy and thromboembolic risk.
  5. Longitudinal Studies and Real-World Evidence:
    There is a trend towards conducting longitudinal and real-world studies to assess the long-term outcomes of various thromboembolic treatments, emphasizing the importance of practical evidence in clinical decision-making.

Declining or Waning

While the journal continues to cover a wide array of topics, some previously prominent areas of focus appear to be declining in frequency or interest, reflecting changes in the clinical landscape and research priorities.
  1. Traditional Antithrombotic Therapies:
    Research on older antithrombotic agents like unfractionated heparin and warfarin is becoming less common as newer therapies gain prominence, leading to a shift in focus towards novel anticoagulants and their comparative effectiveness.
  2. Generalized Risk Factors for Thrombosis:
    While risk factors for thrombosis were once a major focus, there is a noticeable decline in studies addressing generalized risk factors, as researchers are now more focused on specific patient populations and their unique risk profiles.
  3. Non-Pharmacological Interventions:
    Research on non-pharmacological interventions for thrombosis prevention, such as lifestyle modifications or physical therapies, is less frequently published, likely overshadowed by pharmacological advancements.
  4. Thrombolysis Techniques:
    The frequency of studies on traditional thrombolytic techniques appears to be waning, as interest shifts towards more innovative approaches and technologies in thrombectomy and catheter-directed therapies.

Similar Journals

Hamostaseologie

Pioneering Research in Coagulation: Your Gateway to Hematological Insights
Publisher: GEORG THIEME VERLAG KGISSN: 0720-9355Frequency: 4 issues/year

Hamostaseologie is a prominent academic journal dedicated to the field of hematology, published by GEORG THIEME VERLAG KG. With an ISSN of 0720-9355 and an E-ISSN of 2567-5761, this journal has been at the forefront of critical research and advancements since its inception in 1981, and it continues to maintain its relevance in the scientific community with a converged publication until 2024. Ranked in the Q3 quartile in Hematology for 2023, and positioned at #44 out of 137 in the Scopus Medicine Hematology category, it represents a substantial contribution to scholarly discourse. Researchers and professionals alike will find valuable insights within its pages, as it disseminates rigorous studies and reviews that address pertinent issues related to hemostasis and coagulation. While the journal does not currently offer Open Access, readers can access its valuable content through institutional subscriptions, making it an essential resource for students, clinicians, and researchers aiming to deepen their understanding of hematological science.

EUROPEAN RESPIRATORY JOURNAL

Fostering Excellence in Respiratory Research
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Journal of Vascular Surgery-Venous and Lymphatic Disorders

Unveiling the future of vascular surgery and patient care.
Publisher: ELSEVIERISSN: 2213-333XFrequency: 6 issues/year

The Journal of Vascular Surgery-Venous and Lymphatic Disorders, published by Elsevier, is a distinguished peer-reviewed journal dedicated to advancing the knowledge and practice of vascular surgery with a particular focus on venous and lymphatic conditions. With an ISSN of 2213-333X and a robust impact factor, this journal ranks Q2 in Cardiology and Cardiovascular Medicine and Q1 in Surgery, reflecting its high relevance and contribution to the field. Covering a wide spectrum of topics from innovative surgical techniques to the latest developments in venous and lymphatic disorders, the journal serves as a vital resource for researchers, clinicians, and students alike. It not only disseminates cutting-edge research but also promotes best practices and interdisciplinary collaboration within the cardiovascular domain. The journal is accessible to a global audience, ensuring that impactful findings reach practitioners and researchers everywhere, further elevating the standards of patient care and surgical excellence.

AMERICAN JOURNAL OF HEMATOLOGY

Advancing Hematological Science Through Rigorous Research
Publisher: WILEYISSN: 0361-8609Frequency: 12 issues/year

American Journal of Hematology, published by Wiley, stands as a premier outlet for the dissemination of cutting-edge research in the field of hematology. With a commendable impact factor and ranked #9 out of 137 in the Scopus medicine category, this journal has established a robust presence since its inception in 1976. Operating in the Q1 quartile for hematology, it serves as a crucial resource for researchers, clinicians, and students dedicated to understanding blood disorders and advancing treatment methodologies. While the journal does not currently offer open access options, it remains highly regarded for its rigorous peer-review process and impactful contributions to the scientific community. With coverage extending into 2024, the American Journal of Hematology is committed to fostering innovation and collaboration within the hematological sciences.

Lung India

Catalyzing change in pulmonary practices worldwide.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

Annals of Vascular Diseases

Driving Knowledge Forward in Vascular Diseases
Publisher: ANNALS VASCULAR DISEASES EDITORIAL OFFICEISSN: 1881-641XFrequency: 4 issues/year

Annals of Vascular Diseases is a leading international journal dedicated to the comprehensive exploration of vascular pathology, aimed at advancing knowledge in the field through innovative research and insightful reviews. Published by the ANNALS VASCULAR DISEASES EDITORIAL OFFICE and available in both print (ISSN: 1881-641X) and electronic format (E-ISSN: 1881-6428), this journal has embraced Open Access since 2017, facilitating wider dissemination and accessibility of vital research findings. With its focus on clinical and experimental studies relating to vascular diseases, the journal serves as a crucial platform for researchers, medical professionals, and students who seek to stay at the forefront of clinical advancements. By fostering collaboration and sharing knowledge, Annals of Vascular Diseases plays a significant role in shaping the future of vascular research and treatment strategies worldwide.

International Journal of Stroke

Pioneering Insights in Stroke Prevention and Recovery
Publisher: SAGE PUBLICATIONS LTDISSN: 1747-4930Frequency: 9 issues/year

The International Journal of Stroke, published by SAGE PUBLICATIONS LTD, is a leading peer-reviewed journal dedicated to advancing the field of stroke research and clinical practice. Established with a commitment to disseminating high-quality scholarly articles, this journal has rapidly progressed to achieve a prestigious Q1 ranking in both Neurology and Clinical Neurology categories as of 2023. With a remarkably high Scopus rank of #7 among 192 in Neuroscience and #16 among 400 in Clinical Neurology, it places itself firmly in the top 4% of journals in its field, reflecting its significant impact on the academic and clinical landscape. Although it does not currently offer Open Access options, the journal provides a vital platform for researchers and clinicians alike, focusing on innovative treatments, methodologies, and evolving strategies for stroke prevention and recovery. With a publication scope that spans from 2006 to 2024, the International Journal of Stroke continues to foster knowledge exchange and encourage collaboration, making it an essential resource for anyone involved in neurologic healthcare.

NEUROLOGIST

Fostering a Rich Exchange of Neurological Knowledge
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1074-7931Frequency: 6 issues/year

NEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.

Journal of Stroke

Advancing Stroke Research for a Healthier Tomorrow
Publisher: KOREAN STROKE SOCISSN: 2287-6391Frequency: 3 issues/year

Journal of Stroke is a premier open-access journal published by the Korean Stroke Society, dedicated to advancing the understanding of stroke through cutting-edge research and innovative clinical practices. Since its inception in 2013, the journal has gained notable recognition in the fields of Cardiology and Cardiovascular Medicine and Neurology, reflecting its commitment to high-quality, peer-reviewed content, with rankings in the top quartiles (Q1) for both categories as of 2023. The journal’s impact is underscored by its Scopus rankings, placing it in the 92nd and 91st percentiles within its respective fields, thus serving as a vital resource for researchers, clinicians, and students seeking to enhance their knowledge and contribute to stroke research and treatment methodologies. The Journal of Stroke is strategically positioned in South Korea and fosters a global dialogue on stroke-related issues, reinforcing its role as a pivotal platform for disseminating vital findings that can influence both clinical practices and health policy.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Unraveling the Complexities of Blood Disorders
Publisher: ELSEVIER SCIENCE INCISSN: 1538-7933Frequency: 12 issues/year

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, published by Elsevier Science Inc, stands at the forefront of research in the fields of hematology and medicine, boasting an impressive ranking of #5 out of 137 in Scopus's Medicine - Hematology category, with a remarkable 96th percentile. As an essential resource for researchers, clinicians, and students, this journal, identifiable through its ISSN 1538-7933 and E-ISSN 1538-7836, encompasses pioneering studies and reviews that focus on the mechanisms of thrombosis and hemostasis, contributing significantly to advancements in patient care and therapeutic strategies. With an established presence from 2003 through 2024, it has consistently achieved a prestigious Q1 category ranking, reflecting its impactful contributions to the scientific community. Although it operates under a subscription-based model, the journal remains committed to disseminating significant findings that inform best practices in clinical settings and shape future research trajectories.